Piramal Pharma Limited (NSE:PPLPHARMA)

Piramal Pharma Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 27, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	202,431	297,962	170,528	81,683	-	-
Market Cap Growth	-37.85%	74.73%	108.77%	-	-	-
Enterprise Value	243,500	341,742	209,922	130,128	-	-
Last Close Price	152.45	224.60	128.72	66.76	-	-
PE Ratio	-	326.96	956.95	-	-	-
Forward PE	96.01	70.54	42.33	40.39	-	-
PS Ratio	2.27	3.26	2.09	1.15	-	-
PB Ratio	2.51	3.67	2.15	1.21	-	-
P/TBV Ratio	5.19	11.28	6.97	3.51	-	-
P/FCF Ratio	26.64	130.73	58.30	-	-	-
P/OCF Ratio	12.67	33.39	16.98	16.88	-	-
PEG Ratio	1.07	1.58	1.58	1.35	-	-
EV/Sales Ratio	2.73	3.73	2.57	1.84	-	-
EV/EBITDA Ratio	20.32	24.92	18.43	22.58	-	-
EV/EBIT Ratio	61.59	54.01	45.62	-	-	-
EV/FCF Ratio	32.04	149.94	71.77	-	-	-
Debt / Equity Ratio	0.60	0.60	0.60	0.83	0.62	0.54
Debt / EBITDA Ratio	4.29	3.44	4.00	9.21	3.63	2.30
Debt / FCF Ratio	6.38	21.31	16.10	-	-	-
Asset Turnover	0.57	0.59	0.55	0.52	0.57	-
Inventory Turnover	1.34	1.58	1.69	1.94	1.87	-
Quick Ratio	0.66	0.75	0.61	0.64	0.69	0.82
Current Ratio	1.43	1.54	1.25	1.26	1.34	1.47
Return on Equity (ROE)	-0.30%	1.14%	0.24%	-2.77%	6.11%	-
Return on Assets (ROA)	1.31%	2.55%	1.93%	-0.20%	2.96%	-
Return on Invested Capital (ROIC)	-0.29%	1.13%	0.38%	-0.40%	4.62%	9.43%
Return on Capital Employed (ROCE)	2.70%	5.30%	4.20%	-0.40%	5.70%	10.50%
Earnings Yield	-0.12%	0.31%	0.10%	-2.28%	-	-
FCF Yield	3.75%	0.77%	1.71%	-5.89%	-	-
Dividend Yield	0.09%	0.06%	0.08%	-	-	-
Payout Ratio	-	15.88%	-	-	13.30%	-
Buyback Yield / Dilution	-0.21%	-3.67%	-7.85%	-0.95%	-87.83%	-
Total Shareholder Return	-0.12%	-3.61%	-7.76%	-0.95%	-87.83%	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.